Lexeo Therapeutics, Inc. Common StockLXEONASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank25
3Y CAGR-36.4%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
-36.4%/yr
Annual compound
Percentile
P25
Within normal range
vs 3Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2024$35.01M-71.2%
2023$121.47M+57.1%
2022$77.33M-43.1%
2021$135.86M+362.5%
2020$29.37M-